Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Roche Holding AG (OTCQX International Premier:RHHBY)

Wednesday’s Trading Day
31.20 -0.67 / -2.10%
As of Aug 24
Day’s Change
Thursday’s Pre-Market   Switch to standard view »
31.10 -0.1011 / -0.32%
Volume: --
Roche Launches Accu-Chek Blood Glucose Monitoring System
Aug 23 / Zacks.com - Paid Partner Content
Better Buy: AbbVie Inc. vs. Eli Lilly & Co.
Aug 17 / MotleyFool.com - Paid Partner Content
Puma (PBYI) Neratinib's Application Validated in EU, Stock Up
Aug 23 / Zacks.com - Paid Partner Content
Better Buy: Amgen Inc. vs. Biogen
Aug 17 / MotleyFool.com - Paid Partner Content
Innovative Diagnostic and Therapeutic Products Seen at Roche
Aug 22 / GuruFocus News - Paid Partner Content
Epizyme Doses First Patient in Phase II Mesothelioma Study
Aug 15 / Zacks.com - Paid Partner Content
3 Reasons Medivation Is the Juiciest Target in Biotech
Aug 21 / MotleyFool.com - Paid Partner Content
How Risky Is Celldex Therapeutics, Inc.?
Aug 12 / MotleyFool.com - Paid Partner Content

Today’s Trading

Previous close31.87
Today’s open31.58
Day’s range31.18 - 31.68
Average volume (3 months)981,424
Market cap$172.8B
Dividend yield3.26%
Data as of 08/24/2016

Growth & Valuation

Earnings growth (last year)-9.78%
Earnings growth (this year)--
Earnings growth (next 5 years)+7.69%
Revenue growth (last year)-3.39%
P/E ratio--


No competitors data available.


Next reporting dateOctober 18, 2016
EPS forecast (this quarter)$0.92
Annual revenue (last year)$50.0B
Annual profit (last year)$9.2B
Net profit margin18.41%


Health Technology
Pharmaceuticals: Major
Chief Executive Officer &
Executive Director
Severin Schwan
Roche Diagnostics Division
Roland Diggelmann
Corporate headquarters
Basel, Basel-stadt (basle Town)


Partner Offers

Search for Jobs